Hot penny stocks... don't get burned
   

News for Bristol Myers Squibb Co. (BMY)

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
News for BristolMyers Squibb Company  (BMY) 
|
$ 21.49      -0.01 (-0.05%) Volume: 10.33 m 4:01 PM EDT Sep 5, 2008
After Hours:  $ 21.60   0.11 (+0.51%) Volume: 43.86 k 5:10 PM EDT Sep 5, 2008
Wed, Sep 03, 2008
9:38 AM Bristol-Myers Squibb and AstraZeneca to Hold Investor Teleconference to Discuss EASD Highlights - Business Wire
Tue, Sep 02, 2008
6:00 AM Ingenuity Systems Announces Multi-Year Deal With Bristol-Myers Squibb for IPA - PR Newswire
5:02 AM New Data is Presented on Investigational Oral Anticoagulant Apixaban in Acute Coronary Syndrome Patients - Business Wire
Thu, Aug 28, 2008
12:30 PM Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ESC Highlights - Business Wire
Tue, Aug 26, 2008
4:15 PM Bristol-Myers Squibb and Pfizer Provide Update on Apixaban Clinical Development Program - Business Wire
Tue, Aug 19, 2008
4:02 PM Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance to Develop Novel Treatment for Multiple Myeloma - Business Wire
Wed, Aug 13, 2008
4:25 PM ADDING MULTIMEDIA NJ, CT, NY & MD School Districts Join Program That Teaches High School Students How Medicines Are Made - Business Wire
Tue, Aug 12, 2008
11:02 AM NJ, CT, NY & MD School Districts Join Program That Teaches High School Students How Medicines Are Made - Business Wire
Tue, Aug 05, 2008
9:23 PM CORRECTING and REPLACING CASTLE Data Showed Boosted REYATAZ(R) (atazanavir sulfate) and Lopinavir/r Achieved Similar Results for Undetectable Viral Load in Treatment-Naive HIV-1 Infected Patients, Regardless of Gender - Business Wire
1:01 PM BRISTOL-MYERS SQUIBB LAUNCHES SECURE THE FUTURE(R) TECHNICAL ASSISTANCE PROGRAM TO OPTIMIZE COMMUNITY SERVICES FOR COMPREHENSIVE HIV MANAGEMENT IN SUB-SAHARAN AFRICA - Business Wire
11:33 AM CASTLE Data Showed Boosted REYATAZ(R) (atazanavir sulfate) and Lopinavir/r Achieved Similar Results for Undetectable Viral Load in Treatment-Naive HIV-1 Infected Patients, Regardless of Gender - Business Wire
Fri, Aug 01, 2008
1:01 PM Bristol-Myers Squibb Announces Completion of ConvaTec Divestiture - Business Wire
Thu, Jul 31, 2008
10:46 AM Bristol-Myers Squibb Proposes to Acquire ImClone Systems for $60.00 Per Share in Cash - Business Wire
Thu, Jul 24, 2008
8:00 AM Symyx Launches Research Services for Life Sciences - Marketwire
7:29 AM Bristol-Myers Squibb Continues Strong Financial Performance Led by Double-Digit Global Sales Growth - Business Wire
Wed, Jul 23, 2008
8:24 AM Bristol-Myers Squibb and AstraZeneca Submit New Drug Application in the United States and Marketing Authorization Application in Europe for ONGLYZA(TM) (saxagliptin) for the Treatment of Type 2 Diabetes - Business Wire
Mon, Jul 21, 2008
7:32 AM Bristol-Myers Squibb Names Chief Procurement Officer - Business Wire
Tue, Jul 15, 2008
8:29 AM Bristol-Myers Squibb to Announce Results for the Second Quarter of 2008 on July 24 - Business Wire
Fri, Jul 11, 2008
10:47 AM Seven Summits Research Releases Comments on AMAT, CHK, OXY, BMY, and ASH - PR Newswire
Fri, Jun 27, 2008
10:51 AM Seven Summits Research Releases Comments on FSLR, CHK, BMY, EL, and PALM - PR Newswire
Thu, Jun 26, 2008
5:39 PM Bristol-Myers Squibb Completes Acquisition of Kosan Biosciences Incorporated - Business Wire
8:15 AM Bristol-Myers Squibb Completes Tender Offer for Kosan Biosciences Incorporated - Business Wire
Wed, Jun 18, 2008
8:22 AM Bristol-Myers Squibb Announces Expiration of Hart-Scott-Rodino Review Period for Acquisition of Kosan Biosciences Incorporated - Business Wire
Fri, Jun 13, 2008
12:41 PM Data from Phase II Exploratory Study Suggest That ORENCIA(R) (abatacept) May Delay Development of Rheumatoid Arthritis in Adults with Undifferentiated Inflammatory Arthritis - Business Wire
Thu, Jun 12, 2008
8:26 AM ORENCIA(R) (abatacept) Provided an Increasing Degree of Inhibition of Structural Damage Through Three Years in Adults with Moderate to Severe Rheumatoid Arthritis - Business Wire
  Page 1 of 6   Next Page

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia.  Terms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for BMY stock. Download BMY report.
Research Report
Get the full report for FREE
Date:Sep 3, 2008
Price:Free
Pages:5
Document Type:Adobe Acrobat Reader
 Download BMY report
  
Example preview: Research report for Bristol Myers Squibb Co. (BMY) Research report for Bristol Myers Squibb Co. (BMY) Research report for Bristol Myers Squibb Co. (BMY) Research report for Bristol Myers Squibb Co. (BMY)
   
   
   
Attention: Please help us to improve our services by answering the following poll:



Please Leave a comment to tell us how you think we can improve our services.

Your message:
   
   
   
   
Summary
Research Report
Description
Level 2 quotes
Charts
News
Profile
Balance Sheet
Income Statement
Cash Flow Statement
Insiders
SEC Filings
Analyst Recommendation
Earnings Report
Historical Prices
Recent Material Events
Key executives
Comments
   
   
   
   

SPKL shot up 21%


From: OTC Journal
Added: 22 Sep, 2007

   

Add to Google
Add to My Yahoo!
rss
 
 
Home > Companies > Bristol Myers Squibb Co.
Home | Message boards | Newsletters | Latest Comments | VC directory | AIM London Stock Exchange | Canadian stocks | Chinese stocks | Broker Directory
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2008 hotstocked.com - All rights reserved.